PR Newswire02.13.20
4WEB Medical, an orthopedic device company focused on developing implants with an advanced structural design that utilizes its proprietary Truss Implant technology, announced that the company achieved record revenues in 2019. Additionally, in the final quarter of 2019, 4WEB recorded the company's largest quarterly revenue to date.
"With investments in product development, clinical research, and procedural based solutions, 4WEB continues to drive the adoption of its proprietary Truss Implant Technology. In 2019, we achieved a 50 pearcent increase in cases, surgeon users, and revenue for our Total Lateral Solution," said Jim Bruty, senior vice president of Sales and Marketing. "Our growth in the lateral market, coupled with the successful launch of the stand-alone Cervical Spine Truss System, fueled the record fourth-quarter performance."
4WEB Medical offers a complete line of titanium fusion implants for both spine and extremities. Under normal loading conditions, the truss implant design transfers strain to adjacent cellular material stimulating a mechanobiologic response.
Vice President of U.S. Spine Sales Geoff Bigos added, "We are excited with our 2019 performance in a very competitive market. With salesforce expansion, the introduction of new truss technologies, and further global expansion into new markets, we anticipate further significant growth in 2020."
In 2020, 4WEB plans to launch several new products, including anterior and lateral lumbar stand-alone implants as well as an ankle fusion and hammertoe solution.
Last Fall, 4WEB launched and completed the first procedures with the Cervical Spine Truss System-Stand Alone (CSTS-SA).
The CSTS-SA implants incorporate an advanced structural design comprised of the company's proprietary Truss Implant technology. Since receiving U.S. Food and Drug Administration 510(k) clearance in August 2019, the system has been utilized in multiple surgeries.
CSTS-SA is a complete, zero-profile, construct solution that eliminates the need for traditional plate and screw fixation. The device also features an easy-to-use single-step locking mechanism, increasing surgeon confidence and improving procedural efficiency, according to the company.
The manufacturing process used to produce 4WEB’s proprietary Truss Implant Technology creates a hierarchical surface roughness which contains surface features that span from the macro to nano scale. 4WEB’s hierarchical surface roughness has been shown to provide an environment that allows for bone growth and fusion. Additionally, in-vitro testing has also shown that stem cells cultured in an osteogenic medium demonstrate increased expression of certain osteogenic markers on 4WEB’s titanium hierarchical surface roughness compared to smooth titanium and smooth PEEK (polyether ether ketone).
"With investments in product development, clinical research, and procedural based solutions, 4WEB continues to drive the adoption of its proprietary Truss Implant Technology. In 2019, we achieved a 50 pearcent increase in cases, surgeon users, and revenue for our Total Lateral Solution," said Jim Bruty, senior vice president of Sales and Marketing. "Our growth in the lateral market, coupled with the successful launch of the stand-alone Cervical Spine Truss System, fueled the record fourth-quarter performance."
4WEB Medical offers a complete line of titanium fusion implants for both spine and extremities. Under normal loading conditions, the truss implant design transfers strain to adjacent cellular material stimulating a mechanobiologic response.
Vice President of U.S. Spine Sales Geoff Bigos added, "We are excited with our 2019 performance in a very competitive market. With salesforce expansion, the introduction of new truss technologies, and further global expansion into new markets, we anticipate further significant growth in 2020."
In 2020, 4WEB plans to launch several new products, including anterior and lateral lumbar stand-alone implants as well as an ankle fusion and hammertoe solution.
Last Fall, 4WEB launched and completed the first procedures with the Cervical Spine Truss System-Stand Alone (CSTS-SA).
The CSTS-SA implants incorporate an advanced structural design comprised of the company's proprietary Truss Implant technology. Since receiving U.S. Food and Drug Administration 510(k) clearance in August 2019, the system has been utilized in multiple surgeries.
CSTS-SA is a complete, zero-profile, construct solution that eliminates the need for traditional plate and screw fixation. The device also features an easy-to-use single-step locking mechanism, increasing surgeon confidence and improving procedural efficiency, according to the company.
The manufacturing process used to produce 4WEB’s proprietary Truss Implant Technology creates a hierarchical surface roughness which contains surface features that span from the macro to nano scale. 4WEB’s hierarchical surface roughness has been shown to provide an environment that allows for bone growth and fusion. Additionally, in-vitro testing has also shown that stem cells cultured in an osteogenic medium demonstrate increased expression of certain osteogenic markers on 4WEB’s titanium hierarchical surface roughness compared to smooth titanium and smooth PEEK (polyether ether ketone).